MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 50 filers reported holding MERSANA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $110,966,000 | -40.4% | 5,959,520 | -25.1% | 4.70% | -37.3% |
| Q2 2020 | $186,253,000 | +167.0% | 7,959,520 | -33.5% | 7.49% | +105.5% |
| Q1 2020 | $69,748,000 | +1.7% | 11,963,649 | 0.0% | 3.64% | +12.4% |
| Q4 2019 | $68,552,000 | +262.7% | 11,963,649 | 0.0% | 3.24% | +107.2% |
| Q3 2019 | $18,903,000 | -60.8% | 11,963,649 | +0.6% | 1.56% | -53.6% |
| Q2 2019 | $48,172,000 | -23.0% | 11,894,267 | 0.0% | 3.38% | +3.9% |
| Q1 2019 | $62,564,000 | +88.3% | 11,894,267 | +46.0% | 3.25% | +146.4% |
| Q4 2018 | $33,229,000 | -59.2% | 8,144,267 | 0.0% | 1.32% | -62.5% |
| Q3 2018 | $81,443,000 | -44.0% | 8,144,267 | 0.0% | 3.51% | -48.4% |
| Q2 2018 | $145,457,000 | +13.3% | 8,144,267 | 0.0% | 6.81% | +19.3% |
| Q1 2018 | $128,435,000 | -4.0% | 8,144,267 | 0.0% | 5.71% | +3.1% |
| Q4 2017 | $133,810,000 | -5.0% | 8,144,267 | 0.0% | 5.54% | +12.4% |
| Q3 2017 | $140,814,000 | +23.8% | 8,144,267 | 0.0% | 4.93% | +19.1% |
| Q2 2017 | $113,775,000 | – | 8,144,267 | – | 4.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |